To measure the CYP3A4 activity, we performed lytic assays by using a P450-Glo CYP3A4 assay kit (V9001; Promega, WI, USA). Luciferin-IPA was used for the CYP3A4 substrate. We measured the fluorescence activity with a luminometer (Lumat LB 9507; Berthold Technologies, Baden-Wurttemberg, Germany) according to the manufacturer’s instructions. The CYP3A4 activities were normalized with the protein content per well by using a Pierce bicinchoninic acid (BCA) protein assay kit (23227; Thermo Fisher Scientific) according to the manufacturer’s instructions. As an inhibitor of CYP3A4, 10 μM ketoconazole (116-00551; Fujifilm Wako Pure Chemical Industries) was incubated with the substrate.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.